Clinical Trials on Type 2 Diabetes Mellitus(T2DM) in United States

Total 7464 results

Eli Lilly and Company

Active, not recruiting

A Study to Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or Both (SURPASS-PEDS)

Glucose Metabolism Disorders | Diabetes Mellitus, Type 2 | Diabetes Mellitus | Endocrine System Diseases | Type2 Diabetes | Metabolic Disease | T2DM (Type 2 Diabetes Mellitus) | T2D

United States, India, Australia, United Kingdom, Mexico, Brazil, Israel, France, Italy
Novartis Pharmaceuticals

Completed

Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) Assessment of LIK066 in Healthy Subjects and in Patients With Type 2 Diabetes Mellitus (T2DM)

Type 2 Diabetes Mellitus (T2DM)

United States
AstraZeneca
Bristol-Myers Squibb

Completed

Bioavailability Study of Fixed Dose Combination (FDC) Formulations of Dapagliflozin and Metformin XR Versus Individual Component Coadministered to Healthy Subjects in a Fasted State

Type 2 Diabetes Mellitus (T2DM)

United States
Ligand Pharmaceuticals
Medpace, Inc.

Completed

A Comparison Study of the Bioavailability of a Capsule Formulation of LGD-6972 to an Oral Solution Formulation

Type 2 Diabetes Mellitus (T2DM)

United States
Scripps Whittier Diabetes Institute
San Diego State University

Completed

Medical Assistant Health Coaching for Diabetes in Diverse Primary Care Settings (MAC)

Type 2 Diabetes Mellitus (T2DM)

United States
Oramed, Ltd.
Integrium

Completed

A Study to Evaluate the Efficacy and Safety of ORMD-0801 (Oral Insulin) in Patients With Type 2 Diabetes Mellitus

T2DM (Type 2 Diabetes Mellitus)

United States
Oramed, Ltd.
Integrium

Terminated

A Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus

T2DM (Type 2 Diabetes Mellitus)

United States
PegBio Co., Ltd.
Covance

Completed

Dose-finding of PB-119 Administered Subcutaneously Once Weekly Versus Placebo in Subjects With Type 2 Diabetes

Type 2 Diabetes Mellitus (T2DM)

United States
Washington University School of Medicine

Completed

Nutritional Therapy for Diabetic Cardiomyopathy

T2DM (Type 2 Diabetes Mellitus)

United States
PhaseBio Pharmaceuticals Inc.

Completed

Phase 1 Multicenter, Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Response of PE0139 Injection in Adult Subjects With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus (T2DM)

United States
Eli Lilly and Company

Completed

A Study of Tirzepatide (LY3298176) in Healthy Participants and Participants With Type 2 Diabetes (T2DM)

Healthy | Type 2 Diabetes Mellitus (T2DM)

United States, Singapore
East Tennessee State University
Medtronic

Terminated

Comparison of 3 Versus 6-Month Use of CGMS in Non-Insulin Using T2DM Patients

T2DM (Type 2 Diabetes Mellitus) | Continuous Glucose Monitoring

United States
Pfizer

Terminated

Multiple Dose Study Of PF-05231023 In Obese Adult Subjects

Type 2 Diabetes Mellitus (T2DM)

United States
Phoenix VA Health Care System
Bristol-Myers Squibb

Completed

Effects of Saxagliptin on Adipose Tissue Inflammation in Humans

Type 2 Diabetes Mellitus (T2DM)

United States
Pfizer

Recruiting

A Study to Learn How Different Amounts of PF-06954522 Are Tolerated and Act in Adults With Type 2 Diabetes Mellitus

Obesity | Type 2 Diabetes Mellitus (T2DM)

United States
NYU Langone Health

Completed

The Effectiveness of Resistance Training on Glycemic Control for Patients With Type 2 Diabetes in Cardiac Rehabilitation

Cardiovascular Disease | Type 2 Diabetes (T2DM)

United States
ConjuChem

Terminated

Dose-Ranging Study to Evaluate Efficacy and Safety of Weekly CJC-1134-PC in Patients With T2DM on Metformin Monotherapy

Type 2 Diabetes Mellitus (T2DM)

United States, Canada
Kallyope Inc.

Recruiting

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of K-757 and K-833 in Overweight/Obese Patients With Type 2 Diabetes

Obesity | Type 2 Diabetes Mellitus (T2DM)

United States
Center Laboratories, Inc.

Completed

CS02 vs Placebo With Metformin in Type 2 Diabetes Mellitus (T2DM)

T2DM With Inadequate Glycemic Control

Taiwan, United States
Alnylam Pharmaceuticals

Recruiting

A Phase 1/2 Study to Evaluate ALN-KHK in Overweight to Obese Healthy Volunteers and Obese Patients With T2DM

Type 2 Diabetes Mellitus (T2DM)

Canada, United States
University of Florida
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Recruiting

Low-Dose Pioglitazone in Patients With NASH (AIM 2)

Nonalcoholic Steatohepatitis | Type 2 Diabetes Mellitus (T2DM)

United States
NYU Langone Health

Completed

NYULMC CareSmarts Pilot

Diabetes | Type 2 Diabetes (T2D)

United States
Wake Forest University Health Sciences
University of North Carolina, Greensboro

Recruiting

Human Immunodeficiency Virus (HIV) Food Insecurities

PreDiabetes | HIV | Type 2 Diabetes Mellitus (T2DM) | Food Insecurities | Cardiometabolic Comorbidities

United States
University of Florida
Inventiva Pharma

Completed

Lanifibranor in Patients With Type 2 Diabetes & Nonalcoholic Fatty Liver Disease

Nonalcoholic Fatty Liver Disease (NAFLD) | Type 2 Diabetes (T2DM)

United States
Eli Lilly and Company

Active, not recruiting

A Study of Insulin Efsitora Alfa (LY3209590) Compared to Glargine in Adult Participants With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time (QWINT-1) (QWINT-1)

Type 2 Diabetes | T2D

United States, Mexico, Argentina, Puerto Rico
Hanmi Pharmaceutical Company Limited

Unknown

Multiple Ascending Dose Study of HM12470 in Type 1 and Type 2 Diabetes Mellitus

Type2 Diabetes Mellitus | Type1 Diabetes Mellitus

United States
HighTide Biopharma Pty Ltd

Completed

A Study of HTD1801 in Adults With Nonalcoholic Steatohepatitis (NASH) and Type 2 Diabetes Mellitus (T2DM)

Digestive System Diseases | NAFLD | Nonalcoholic Fatty Liver Disease | Nonalcoholic Steatohepatitis | Type 2 Diabetes Mellitus (T2DM) | Fatty Liver, Nonalcoholic

United States
University of Colorado, Denver

Recruiting

Uric Acid Lowering Trial in Youth Onset T2D (ULTRA-T2D)

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Complications | Type 2 Diabetes Mellitus | Diabetic Kidney Disease | Diabetic Nephropathies | Type2 Diabetes | Hyperuricemia

United States
Virginia Commonwealth University

Completed

Diabetes Engagement and Activation Platform (DEAP)

Type 2 Diabetes (T2D)

United States
University of Michigan
Eli Lilly and Company; Amylin Pharmaceuticals, LLC.

Completed

Evaluation of Exenatide in Patients With Diabetic Neuropathy

Type 2 Diabetes Mellitus | Diabetic Peripheral Neuropathy

United States
University of Southern California
Project Angel Food; United American Indian Involvement, Inc.

Active, not recruiting

Native American Diabetes Project

Diabetes Mellitus, Type 2 | Diabetes Mellitus | Diabetes | Diabetes Mellitus, Type 1 | Diabetes Type 1 | Diabete Type 2

United States
Joslin Diabetes Center
Cambridge Medical Technologies, LLC

Completed

PRECISION Study: Evaluating the Accuracy of the LabPatch Continuous Glucose Monitor

Type 2 Diabetes Mellitus | Type1 Diabetes Mellitus

United States
Pfizer

Completed

Multiple Dose Study Of PF-05231023 In Adult Subjects Who Have Poor Lipid Control With And Without Type 2 Diabetes Mellitus

Diabetes Melliuts, Type 2

United States
Theracos

Completed

Bexagliflozin Drug/Drug Interaction Study With Exenatide Injection

Type2 Diabetes Mellitus

United States
The University of Texas at San Antonio
American Diabetes Association

Unknown

Building a Healthy Temple: a Diabetes Self-management Support Program in Hispanic Faith Community Settings

Type2 Diabetes Mellitus

United States
West Side Institute for Science and Education

Completed

Tolerance & Responsiveness Improvement for Metformin (TRIM)

Type2 Diabetes Mellitus

United States
Georgia Institute of Technology
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Emory...

Completed

Guide To Goals: A Novel Care Coordination Tool for Children With Type Two Diabetes (T2D) (GTG)

Type2 Diabetes Mellitus

United States
Theracos

Completed

Interaction of Bexagliflozin With Metformin, Glimepiride and Sitagliptin

Type2 Diabetes Mellitus

United States
University of Minnesota

Completed

The Influence of Physical Activity on the Gut Microbiome of Pre-Diabetic Adults

Obesity | Overweight | Type 2 Diabetes Mellitus | PreDiabetes | Type 2 Diabetes | Type 2 Diabetes Mellitus in Obese | Overweight and Obesity

United States
Theracos

Completed

Bexagliflozin Drug/Drug Interaction Study With Digoxin

Type2 Diabetes Mellitus

United States
VA Sierra Nevada Health Care System

Completed

Use of a Smart-phone Based Medication Adherence Platform to Improve Outcomes in Uncontrolled Non-insulin Dependent Diabetes Among Veterans

Diabetes | Diabete Type 2

United States
Yale University
National Center for Advancing Translational Sciences (NCATS)

Withdrawn

Reversibility of Brain Glucose Transport and Metabolism in T2DM: an Intervention Study

Diabete Type 2

United States
Des Moines University

Completed

Habit Formation for Diabetes Self-Management

Diabete Type 2

United States
University of Chicago
Northwestern University; National Institute on Aging (NIA)

Active, not recruiting

Behavioral Chronotype: Impact on Sleep and Metabolism

Cardiovascular Diseases | Type2 Diabetes Mellitus

United States
Theracos

Completed

Safety and Efficacy of Bexagliflozin in Subjects With Moderate Hepatic Impairment

Type2 Diabetes Mellitus

United States
PegBio Co., Ltd.

Completed

MAD Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PB-119 to Subjects With T2DM

Type2 Diabetes Mellitus

United States
Spaulding Rehabilitation Hospital
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Not yet recruiting

Deploying Digital Prosthetic Interface Technology and Exercise in Dysvascular Amputees

Amputation | Diabete Type 2

United States
Rutgers, The State University of New Jersey

Completed

Fiber Mix and Glycemic Response

Type2 Diabetes Mellitus

United States
University of California, Los Angeles

Completed

Investigation of PJ vs. Sugar on Glucose Levels in Healthy and Prediabetic Subjects (PSW)

Pre Diabetes | Diabete Type 2

United States
AstraZeneca
Quotient Sciences

Completed

A Randomised, Open-Label Study to Evaluate the Relative and Absolute Bioavailability of Cotadutide in Healthy Subjects

Chronic Kidney Disease | Type 2 Diabetes Mellitus (T2DM) | Non-alcoholic Steatohepatitis

United Kingdom

Clinical Trials on Type 2 Diabetes Mellitus(T2DM) in United States

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Kingdom

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations